Metagenomi (MGX) Return on Sales (2023 - 2025)
Metagenomi (MGX) has disclosed Return on Sales for 3 consecutive years, with 5.76% as the latest value for Q4 2025.
- On a quarterly basis, Return on Sales fell 333.0% to 5.76% in Q4 2025 year-over-year; TTM through Dec 2025 was 3.49%, a 199.0% decrease, with the full-year FY2025 number at 3.49%, down 199.0% from a year prior.
- Return on Sales was 5.76% for Q4 2025 at Metagenomi, down from 2.36% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.54% in Q2 2024 to a low of 6.07% in Q1 2025.
- A 3-year average of 2.45% and a median of 1.94% in 2024 define the central range for Return on Sales.
- Peak YoY movement for Return on Sales: skyrocketed 100bps in 2024, then tumbled -381bps in 2025.
- Metagenomi's Return on Sales stood at 1.56% in 2023, then crashed by -56bps to 2.43% in 2024, then crashed by -137bps to 5.76% in 2025.
- Per Business Quant, the three most recent readings for MGX's Return on Sales are 5.76% (Q4 2025), 2.36% (Q3 2025), and 2.34% (Q2 2025).